Scarica l'app Stockscreener
4.2999
0.12%
0.0099
Precedente Chiudi:
$4.29
Aprire:
$4.26
Volume 24 ore:
202.83K
Relative Volume:
0.36
Capitalizzazione di mercato:
$90.13M
Reddito:
-
Utile/perdita netta:
$-94.11M
Rapporto P/E:
-0.7155
EPS:
-6.01
Flusso di cassa netto:
$-86.06M
1 W Prestazione:
+0.82%
1M Prestazione:
-20.32%
6M Prestazione:
+23.07%
1 anno Prestazione:
-43.04%
Intervallo 1D:
$4.26
$4.305
Intervallo di 1 settimana:
$4.18
$4.34
Portata 52W:
$1.78
$8.18
Adverum Biotechnologies Inc Stock (ADVM) Company Profile
Nome
Adverum Biotechnologies Inc
Settore
Industria
Telefono
(650) 649-1004
Indirizzo
100 CARDINAL WAY, REDWOOD CITY, CA
Confronta ADVM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADVM
Adverum Biotechnologies Inc
|
4.295 | 94.37M | 0 | -94.11M | -86.06M | -6.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.89 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
635.15 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
428.03 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
841.58 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.56 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-25 | Iniziato | Oppenheimer | Outperform |
| 2024-04-30 | Iniziato | H.C. Wainwright | Buy |
| 2022-07-07 | Aggiornamento | Truist | Hold → Buy |
| 2021-07-23 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-05-03 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-04-29 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2021-04-29 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-04-29 | Downgrade | Truist | Buy → Hold |
| 2020-12-16 | Iniziato | UBS | Neutral |
| 2020-11-12 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2020-06-26 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2020-05-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-05-05 | Aggiornamento | SunTrust | Hold → Buy |
| 2020-04-28 | Iniziato | Goldman | Buy |
| 2020-03-16 | Iniziato | SVB Leerink | Outperform |
| 2020-02-10 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2020-02-10 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2019-10-15 | Reiterato | Chardan Capital Markets | Neutral |
| 2019-09-13 | Reiterato | Chardan Capital Markets | Neutral |
| 2019-06-14 | Ripresa | Raymond James | Mkt Perform |
| 2018-11-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2018-11-02 | Downgrade | SunTrust | Buy → Hold |
| 2018-09-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-08-30 | Iniziato | SunTrust | Buy |
| 2018-02-15 | Ripresa | Piper Jaffray | Overweight |
| 2017-10-12 | Iniziato | Raymond James | Outperform |
Mostra tutto
Adverum Biotechnologies Inc Borsa (ADVM) Ultime notizie
Will Adverum Biotechnologies Inc. stock deliver consistent dividendsBuy Signal & Breakout Confirmation Trade Signals - newser.com
Has Adverum Biotechnologies Inc. found a price floorTrade Risk Summary & Daily Stock Trend Watchlist - newser.com
What the charts say about Adverum Biotechnologies Inc. today2025 Historical Comparison & Real-Time Stock Movement Alerts - newser.com
Volume spikes in Adverum Biotechnologies Inc. stock – what they meanWeekly Trade Review & Daily Profit Maximizing Tips - newser.com
Detecting price anomalies in Adverum Biotechnologies Inc. with AI2025 Price Action Summary & Safe Swing Trade Setup Alerts - newser.com
Is Adverum Biotechnologies Inc. stock poised for growthMarket Trend Review & Daily Stock Momentum Reports - newser.com
Chart overlay techniques for tracking Adverum Biotechnologies Inc.Weekly Market Summary & Weekly High Potential Stock Alerts - newser.com
Will Adverum Biotechnologies Inc. (AVU0) stock benefit from mergersInflation Watch & Verified Stock Trade Ideas - newser.com
Is Adverum Biotechnologies Inc. stock attractive for growth ETFs2025 Volatility Report & Real-Time Buy Zone Alerts - newser.com
Is it too late to sell Adverum Biotechnologies Inc.Portfolio Gains Summary & Stepwise Entry/Exit Trade Alerts - newser.com
How rising interest rates impact Adverum Biotechnologies Inc. stockQuarterly Trade Summary & Intraday High Probability Alerts - newser.com
Real time social sentiment graph for Adverum Biotechnologies Inc.July 2025 Setups & High Yield Equity Trading Tips - newser.com
How interest rate cuts could boost Adverum Biotechnologies Inc. stockPortfolio Update Report & Weekly High Potential Stock Alerts - newser.com
Eli Lilly To Acquire Adverum Biotechnologies - MSN
RBC Capital Maintains Adverum Biotechnologies (ADVM) Sector Perform Recommendation - MSN
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Mizuho Cuts Price Target on Adverum Biotechnologies to $5.50 From $12, Keeps Outperform Rating - MarketScreener
What drives Adverum Biotechnologies Inc AVU0 stock priceEarnings Revision Updates & Free Grow Wealth With Picks - earlytimes.in
Lilly to purchase Adverum Biotechnologies - Eyes On Eyecare
RBC Raises Price Target on Adverum Biotechnologies to $4 From $3, Keeps Sector Perform, Speculative Risk - MarketScreener
Adverum Biotechnologies (NASDAQ:ADVM) Stock Rating Lowered by Chardan Capital - MarketBeat
With Adverum Biotechnologies Stock Down 6.0% In A Month, How Confident Are You? - Trefis
How Adverum Biotechnologies Inc. (AVU0) stock responds to bond marketMarket Growth Report & Free Community Consensus Stock Picks - fcp.pa.gov.br
With Adverum, Eli Lilly Made A Small Bet That Could Pay Off Big (NYSE:LLY) - Seeking Alpha
Eli Lilly Taps Eyecare Market With Definitive Agreement to Acquire Adverum Biotechnologies - VisionMonday.com
Adverum Biotechnologies Inc Azioni (ADVM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.73%
0.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):